Cargando…
RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression
Ovarian cancer is one of the most lethal gynecologic malignancies for women. Due to the lack of efficient target therapy, the overall survival rate for patients with advanced ovarian cancer is still low. Illustrating the molecular mechanisms dictating ovarian cancer progression is critically importa...
Autores principales: | Fu, Chunhong, Yuan, Ming, Sun, Jie, Liu, Gang, Zhao, Xiaojuan, Chang, Wei, Ma, Zhongling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382552/ https://www.ncbi.nlm.nih.gov/pubmed/34434291 http://dx.doi.org/10.1155/2021/3037337 |
Ejemplares similares
-
The RNA recognition motif protein RBM11 is a novel tissue-specific splicing regulator
por: Pedrotti, Simona, et al.
Publicado: (2012) -
UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer
por: Sun, Qiran, et al.
Publicado: (2023) -
RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers
por: Wang, Jianke, et al.
Publicado: (2020) -
SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020) -
Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis
por: Wang, Wen, et al.
Publicado: (2019)